selected publications
- Radiation Oncology-Biology Integration Network (ROBIN): Bridging the gap between biological research and clinical practice. Clinical cancer research : an official journal of the American Association for Cancer Research. 2026 Academic Article GET IT
-
Soluble MAdCAM-1 as a biomarker in metastatic renal cell carcinoma.
Nature medicine.
2026
Academic Article
GET IT
Times cited: 1 -
Facts and Hopes in Radioimmunotherapy for Localized Stages of Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2026
Information Resource
GET IT
Times cited: 2 - RISE UP for breast cancer 2024: conference highlights & takeaways. Breast cancer research and treatment. 2026 Information Resource GET IT
- Rewriting the radiation playbook: NSABP B-51 and the rise of pathologic precision. NPJ breast cancer. 2025 Information Resource GET IT
- Gut microbiota: a new factor modulating the immunizing potential of viral and cancer vaccines. Research square. 2025 Article GET IT
- Author Correction: IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages. Nature cancer. 2025 Article GET IT
-
Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non-small cell lung cancer.
The Journal of thoracic and cardiovascular surgery.
2025
Academic Article
GET IT
Times cited: 2 -
Safety and efficacy of bridging radiation therapy prior to CD19 CAR T for non-Hodgkin lymphoma: a systematic review and meta-analysis.
Haematologica.
2025
Information Resource
GET IT
Times cited: 1 -
IL-17A-secreting γδ T cells promote resistance to CDK4/CDK6 inhibitors in HR+HER2- breast cancer via CX3CR1+ macrophages.
Nature cancer.
2025
Academic Article
GET IT
Times cited: 17 - A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single Institution. European urology oncology. 2025 Academic Article GET IT
-
Treatment deescalation for older women with favorable breast cancers: patient values and shared decision making.
Journal of the National Cancer Institute.
2025
Article
GET IT
Times cited: 1 -
Heart and Left Anterior Descending Coronary Artery (LAD) Exposure from Hypo-Fractionated Whole Breast Radiotherapy with a Prone Setup.
Cancers.
2025
Academic Article
GET IT
Times cited: 1 -
Impact of radiation therapy dose, fractionation, and immunotherapeutic partner in a mouse model of hormone receptor-positive mammary carcinogenesis.
Journal of the National Cancer Institute.
2025
Academic Article
GET IT
Times cited: 7 -
Topical TLR7 agonist and radiotherapy in patients with metastatic breast cancer.
Journal for immunotherapy of cancer.
2025
Academic Article
GET IT
Times cited: 5 - Total body irradiation primes CD19-directed CAR T cells against large B-cell lymphoma. bioRxiv : the preprint server for biology. 2025 Article GET IT
-
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients.
Cancer cell.
2025
Academic Article
GET IT
Times cited: 33 -
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.
The Lancet. Oncology.
2025
Conference Paper
GET IT
Times cited: 23 -
Phase 1-2 Study of Prone Hypofractionated Accelerated Breast and Nodal Intensity Modulated Radiation Therapy.
International journal of radiation oncology, biology, physics.
2025
Academic Article
GET IT
Times cited: 3 -
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.
Oncoimmunology.
2024
Conference Paper
GET IT
Times cited: 5 -
Tumor-Associated Lymphocytes and Breast Cancer Survival in Black and White Women.
JAMA surgery.
2024
Academic Article
GET IT
Times cited: 6 -
Biological Insights and Radiation-Immuno-Oncology Developments in Primary and Secondary Brain Tumors.
Cancers.
2024
Information Resource
GET IT
Times cited: 6 -
A Radiation Therapy Contouring Atlas for Delineation of the Level I and II Axillae in the Prone Position: A Single-Institution Experience.
Practical radiation oncology.
2024
Academic Article
GET IT
Times cited: 3 -
Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.
Journal of visualized experiments : JoVE.
2024
Academic Article
GET IT
Times cited: 1 -
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives.
International journal of radiation oncology, biology, physics.
2024
Information Resource
GET IT
Times cited: 26 - Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial. Nature communications. 2024 Article GET IT
-
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
Nature communications.
2023
Academic Article
GET IT
Times cited: 37 -
Immunologically relevant effects of radiation therapy on the tumor microenvironment.
Essays in biochemistry.
2023
Academic Article
GET IT
Times cited: 6 -
CD40 agonism improves anti-tumor T cell priming induced by the combination of radiation therapy plus CTLA4 inhibition and enhances tumor response.
Oncoimmunology.
2023
Academic Article
GET IT
Times cited: 4 -
Immunotherapy targeting different immune compartments in combination with radiation therapy induces regression of resistant tumors.
Nature communications.
2023
Academic Article
GET IT
Times cited: 44 -
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).
BMC cancer.
2023
Academic Article
GET IT
Times cited: 7 -
National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities.
The Lancet. Oncology.
2023
Information Resource
GET IT
Times cited: 33 -
Perspectives in Immunotherapy: meeting report from Immunotherapy Bridge (Naples, November 30th-December 1st, 2022).
Journal of translational medicine.
2023
Conference Paper
GET IT
Times cited: 6 -
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6th annual ImmunoRad conference.
Oncoimmunology.
2023
Information Resource
GET IT
Times cited: 11 -
Emerging evidence for adapting radiotherapy to immunotherapy.
Nature reviews. Clinical oncology.
2023
Information Resource
GET IT
Times cited: 295 -
Radiation therapy improves CAR T cell activity in acute lymphoblastic leukemia.
Cell death & disease.
2023
Academic Article
GET IT
Times cited: 33 -
AN0025, a novel antagonist of PGE2-receptor E-type 4 (EP4), in combination with total neoadjuvant treatment of advanced rectal cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
2023
Academic Article
GET IT
Times cited: 6 -
Cellular senescence in the response of HR+ breast cancer to radiotherapy and CDK4/6 inhibitors.
Journal of translational medicine.
2023
Academic Article
GET IT
Times cited: 17 -
MRI-LINAC: A transformative technology in radiation oncology.
Frontiers in oncology.
2023
Information Resource
GET IT
Times cited: 72 -
The initial experience of MRI-guided precision prone breast irradiation with daily adaptive planning in treating early stage breast cancer patients.
Frontiers in oncology.
2022
Academic Article
GET IT
Times cited: 10 -
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study.
Cancers.
2022
Academic Article
GET IT
Times cited: 3 -
Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City.
American journal of surgery.
2022
Academic Article
GET IT
Times cited: 8 -
Author Correction: Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.
Nature reviews. Clinical oncology.
2022
Article
GET IT
Times cited: 1 -
Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer.
Nature reviews. Clinical oncology.
2021
Information Resource
GET IT
Times cited: 192 -
3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine.
Nature communications.
2021
Academic Article
GET IT
Times cited: 51 -
Radiotherapy Delivered before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2021
Academic Article
GET IT
Times cited: 58 -
Activin A Promotes Regulatory T-cell-Mediated Immunosuppression in Irradiated Breast Cancer.
Cancer immunology research.
2020
Academic Article
GET IT
Times cited: 57 -
Converging focal radiation and immunotherapy in a preclinical model of triple negative breast cancer: contribution of VISTA blockade.
Oncoimmunology.
2020
Academic Article
GET IT
Times cited: 49 - Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature communications. 2020 Article GET IT
-
Mitochondrial DNA drives abscopal responses to radiation that are inhibited by autophagy.
Nature immunology.
2020
Academic Article
GET IT
Times cited: 322 -
Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer.
Nature communications.
2020
Academic Article
GET IT
Times cited: 112 -
Cancer and COVID-19 - potentially deleterious effects of delaying radiotherapy.
Nature reviews. Clinical oncology.
2020
Information Resource
GET IT
Times cited: 65 -
Immunomodulation by anticancer cell cycle inhibitors.
Nature reviews. Immunology.
2020
Information Resource
GET IT
Times cited: 124 -
Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.
International journal of radiation biology.
2019
Information Resource
GET IT
Times cited: 70 -
Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
Nature medicine.
2018
Academic Article
GET IT
Times cited: 821 - Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015. Journal of translational medicine. 2016 Academic Article GET IT